Blueprint Medicines
BPMC
$108.78
Share price
0.21%
Change (1 day)
98.87%
Change (1 year)
Categories
EPS for Blueprint Medicines (BPMC)
EPS in 2023 (TTM): -$9.19
According to Blueprint Medicines 's latest financial reports the company's current EPS (TTM) is -$9.19. In 2022 the company made an earnings per share (EPS) of -$9.35 an increase over its 2021 EPS that were of -$10.98.
EPS history for Blueprint Medicines from 2014 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$9.19 | -1.71% |
| 2022 | -$9.35 | -14.85% |
| 2021 | -$10.98 | -297.13% |
| 2020 | $5.57 | -176.3% |
| 2019 | -$7.30 | 35.19% |
| 2018 | -$5.40 | 38.82% |
| 2017 | -$3.89 | 47.35% |
| 2016 | -$2.64 | 9.25% |
| 2015 | -$2.42 | -31.35% |
| 2014 | -$3.52 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Pacific Biosciences
PACB | -$1.27 | -86.18% | 🇺🇸 USA |
 OPKO Health
OPK | -$0.27 | -97.06% | 🇺🇸 USA |
 Isoray
ISR | -$0.07000 | -99.24% | 🇺🇸 USA |